Sign In
Buy MRNA
$47.44
-4.15 (-8.04%)
At Close: Jun 05, 2026
Is It Time to Buy the S&P 500's 2 Worst-Performing February Stocks?
10:55am, Friday, 17'th Mar 2023 The Motley Fool
Lumen Technologies and Moderna just tumbled, but are these buying opportunities or falling knives?
Better RSV Vaccine Stock: Pfizer, GSK, or Moderna?
08:45am, Friday, 17'th Mar 2023
The vaccine's revenue would help Pfizer make up for looming patent cliffs. GSK's annual financials were the healthiest of the three companies.
Moderna (MRNA) Gains But Lags Market: What You Should Know
09:45pm, Thursday, 16'th Mar 2023 Zacks Investment Research
Moderna (MRNA) closed at $151.78 in the latest trading session, marking a +1.46% move from the prior day.
This High-Growth Company Is Expanding. Time to Buy the Stock?
06:00pm, Thursday, 16'th Mar 2023 The Motley Fool
Moderna shares have lost about 15% so far this year.
This High-Growth Company Is Expanding. Time to Buy the Stock?
02:00pm, Thursday, 16'th Mar 2023
Moderna recently announced an expansion plan, which includes hiring new employees and opening new offices. This is a sign of the company's confidence in its own future.
Is First Trust Health Care AlphaDEX ETF (FXH) a Strong ETF Right Now?
10:20am, Thursday, 16'th Mar 2023 Zacks Investment Research
Smart Beta ETF report for FXH
Is First Trust NYSE Arca Biotechnology ETF (FBT) a Strong ETF Right Now?
10:20am, Thursday, 16'th Mar 2023 Zacks Investment Research
Smart Beta ETF report for FBT
Pfizer (PFE) Gets FDA Nod for Bivalent COVID Jab in Infants
06:38pm, Wednesday, 15'th Mar 2023 Zacks Investment Research
Pfizer (PFE) and partner BioNTech receive FDA label expansion to use their Omicron BA.4/BA.5-adapted bivalent COVID-19 vaccine as a single booster dose in young children under five years.
Moderna, Inc. (MRNA) is Attracting Investor Attention: Here is What You Should Know
01:00pm, Wednesday, 15'th Mar 2023 Zacks Investment Research
Zacks.com users have recently been watching Moderna (MRNA) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Moderna, Inc. (MRNA) is Attracting Investor Attention: Here is What You Should Know
10:42am, Wednesday, 15'th Mar 2023
Zacks.com users have recently been watching Moderna (MRNA) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
2 Top Biotech Stocks to Buy for the Long Haul
09:30am, Wednesday, 15'th Mar 2023 The Motley Fool
These companies have what it takes to grow their revenues -- and their share prices -- over time.
3 Vaccine Stocks to Watch for Their Post-Pandemic Moves
09:44pm, Tuesday, 14'th Mar 2023
During the Covid-19 pandemic, vaccine stocks shot up on the promise that they could end the lockdowns. Many vaccines were developed, but few were approved.
Is It Time to Buy the Nasdaq's 3 Worst-Performing February Stocks?
01:30pm, Tuesday, 14'th Mar 2023 The Motley Fool
It might be the beginning of a long road for this trio.
Is It Time to Buy the Nasdaq's 3 Worst-Performing February Stocks?
09:30am, Tuesday, 14'th Mar 2023
JD.com is based in China, which is why many investors stay away from it. Even in a tough advertising market, SiriusXM managed to grow.
A Bull Market Is Coming: 5 Top Stocks to Buy Now
09:30am, Tuesday, 14'th Mar 2023 The Motley Fool
These companies all have solid long-term prospects.
